Home/ Supplements/ Lysine/ All- Basic 677 Milligrams

All- Basic 677 Milligrams

product on market Capsule Montiff Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade
Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for All- Basic 677 Milligrams
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
200
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Proprietary Blend
677 mg
L-Threonine
L-Alanine
L-Histidine
L-Valine
Ornithine-{alpha}-Ketoglutarate
Alpha-Glucan Oligosaccharide
L-Glutamic Acid
Glycine
L-Phenylalanine
L-Serine
L-Proline

Other Ingredients

Gelatin Microcrystalline Cellulose Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one to two capsules daily, or as recommended by a health care professional. To be used as a dietary supplement in a normal food program.

It is recommended that this product be taken with vitamins and minerals.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Formulation Notes

Certified free of: Starch, corn, milk, wheat, yeast, sugar, eggs, salt, soy, artificial colors,binders, flavors, preservatives and fish derivatives.

Additional Information

Highest Quality Available

The unique balance of ingredients found in All-Basic is not found in any other supplement product.

DO NOT REFRIGERATE.

STORE IN COOL, DRY PLACE.

Product#10020

MONTIFF - A DON TYSON COMPANY

Metadata

Product Details

UPC / SKU6 83268 10020 2
DSLD Entry Date2015-02-25
Product TypeAmino acid/Protein
FormCapsule
BrandMontiff
DSLD ID42000
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.